Invitrogen

(IVGN)

expanded its Grand Island, N.Y., campus production capabilities for animal-origin free advanced granulation technology media.

Carlsbad, Calif.-based company invested over $9 million in the facility to transform the 11,000 square feet of existing space on the campus to address several functions, including production of AGT media for internal research projects, internalization of technology for contract manufacturing capabilities and reduction of manufacturing costs.

"Animal component free production of AGT continues an advantage that Invitrogen enjoys in the industry," the company said. "As we move forward, we will look to increase production capability to meet our customers' need for new variations of our proprietary technology."

This story was created through a joint venture between TheStreet.com and IRIS.